 |  |  |  | | February 28, 2013 |  |  |  |  |  |  | | |  | |
'What's NEW with Novel Therapies?'
IMF Teleconference
Brian G.M. Durie, MD
Sagar Lonial, MD
Archived HERE
Thursday, March 7, 2013
4 pm PT/ 7 pm ET
'How to Prevent Infection in Myeloma Patients'
Living Well With Myeloma Teleconference Series
Led by Senu Apewokin, MD
Saturday, March 16, 2013
Living Well with
Myeloma Town Hall
MD Anderson Cancer Center
Houston, Texas
Saturday, March 23, 2013
Jacksonville Myeloma Center Workshop
Jacksonville, Florida
| | | Join the IMF's Patient & Family Seminar This Saturday Via Live Stream! |  | | We're kicking off March Myeloma Awareness Month on Saturday by live streaming our signature Patient & Family Seminar from Boca Raton, Florida! During the broadcast, you can watch myeloma experts discuss and answer questions about clinical trials, new drugs, and what the future holds for myeloma patients. Panelists will include IMF Chairman and Co-Founder Brian GM Durie, MD; Sagar Lonial, MD; Paul Richardson, MD; and Robert Kyle, MD. Live streaming begins Saturday, March 2, at 8:00 am ET/ 5:00 am PT — when IMF Co-Founder and President Susie Novis kicks off the event—and continues till 2:30 pm ET / 11:30 am PT. GO HERE TO VIEW LIVE STREAM BROADCAST |
|
 | | Medicare and You: Navigating the Changing Health Insurance System |  | | Please join us on Thursday, March 21, 2013, at 4 pm PT/ 7 pm ET, for a webinar on the provisions of Health Reform that impact Medicare patients today, and starting in 2014. Next year, with the full implementation of health care reform, there will be many changes to the Medicare system, including the continued closure of the "donut hole" for prescription drugs. To help clarify what these changes mean for patients, we will be joined by a panel of experts on Medicare and Health Care Reform. This will be the first in a series of teleconferences that will focus on health care reform implementation. CLICK HERE to register. | |
| | New IMF Publications Help Patients Understand POMALYST® |  | | Pomalyst®, also known by its generic name, pomalidomide, is the newest in the line of anti-myeloma agents called immunomodulatory drugs, or IMiDs®, agents that can modify or regulate the functioning of the immune system. The IMF's "Understanding Pomalyst®" booklet and tip card feature information on Pomalyst: how it works; the results of clinical trials and ongoing research; how and when to take it; and possible side effects and their management. VIEW PDFs OR REQUEST PRINT VERSIONS HERE | |
| | Nurse Leadership Board Members Offer VELCADE® Sub-Q White Paper |  | | Members of the IMF's Nurse Leadership Board (NLB) gathered at the 2012 American Society of Hematology (ASH) Annual Meeting in Atlanta, Georgia, to discuss the recently FDA-approved subcutaneous (SQ) administration of VELCADE® in myeloma patients. Their findings and recommendations about practices are described in a "white paper" available HERE. |
|
|
| N. Carolina Myeloma Patient Honored with Day of Fun and Fundraising |
 |
| Greensboro, North Carolina myeloma survivor Cynthia Howard will be honored on Saturday, April 13, as area friends and family gather for the Cynthia's "Pack" 5K Fun Walk. The "pack" is a local group of survivors who regularly help one another and are now extending the invitation to the community to raise awareness and funds for myeloma. The day's events will include a bake sale and raffle before and after the walk, which begins at the Sedgefield Country Club in Greensboro. READ MORE |
|
| | | Join Our Mailing List |
| | | |
|
=
|
 related articles
|
step 1: get the correct diagnosis
publications
back
print